Results 1 to 10 of about 592,211 (297)

Fatal anaphylactic shock following cefoperazone–sulbactam re-exposure: a short report on systemic gaps in adverse drug reaction management [PDF]

BMJ Open Quality
This report presents a case of fatal anaphylactic shock following re-exposure to cefoperazone-sulbactam, highlighting systemic gaps in adverse drug reaction (ADR) management.
LiLi Xu, Xiaomei Mo, Guanhua Liang, Wenhui Gan, Meixing Yan   +4 more
doaj   +2 more sources

Adverse cutaneous drug reaction

Indian Journal of Dermatology, 2008
In everyday clinical practice, almost all physicians come across many instances of suspected adverse cutaneous drug reactions (ACDR) in different forms.
Nayak Surajit, Acharjya Basanti
doaj   +3 more sources

Intensive Adverse Drug Reaction Monitoring Program Improves Detection of Phenytoin-Induced Adverse Drug Reactions [PDF]

Patient Preference and Adherence
Suteera Dawdan,1,* Natapohn Chaipichit,2,3,* Apirak Sribhutorn,4– 6 Narumol Jarernsiripornkul7 1Department of Pharmacy, Phrae Hospital, Phrae, Thailand; 2Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University ...
Dawdan S, Chaipichit N, Sribhutorn A, Jarernsiripornkul N   +3 more
doaj   +2 more sources

Adverse drug reactions [PDF]

BMJ, 2018
Summary Adverse drug reactions are a cause of significant morbidity and mortality to patients and a source of financial burden to the healthcare system. Of the wide spectrum of adverse drug reactions, the most concerning to the anaesthetist remain anaphylaxis and malignant hyperthermia.
Ferner, RE, McGettigan, P
  +9 more sources

Adverse drug reactions [PDF]

Clinical Medicine, 2016
Adverse drug reactions (ADRs) remain a challenge in modern healthcare, particularly given the increasing complexity of therapeutics, an ageing population and rising multimorbidity. This article summarises some of the key facts about ADRs and explores aspects relating to their prevention, diagnosis, reporting and management in current clinical practice.
Jamie J, Coleman, Sarah K, Pontefract
openaire   +4 more sources

Novel Therapeutic Targets in Liver Fibrosis

Frontiers in Molecular Biosciences, 2021
Liver fibrosis is end-stage liver disease that can be rescued. If irritation continues due to viral infection, schistosomiasis and alcoholism, liver fibrosis can progress to liver cirrhosis and even cancer.
Jinhang Zhang, Qinhui Liu, Jinhan He, Jinhan He, Yanping Li   +4 more
doaj   +1 more source

Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam

Frontiers in Pharmacology, 2022
Background: The World health organization (WHO) recently recommended standardized all-oral shorter regimens for rifampicin resistant Tuberculosis (RR-TB).
Thi Mai Phuong Nguyen, Binh Hoa Nguyen, Thi Thanh Thuy Hoang, Hoang Anh Nguyen, Dinh Hoa Vu, Mai Hoa Nguyen, Bao Ngoc Nguyen, Tom Decroo, Viet Nhung Nguyen   +8 more
doaj   +1 more source

Study of prescribing errors of two different prescription systems: pre-printed prescription from historical medication and hand-written prescription [PDF]

Pharmaceutical Sciences Asia, 2022
A retrospective observational study of 1,160 prescriptions with prescribing errors from a large academic hospital in Thailand from 2014 to 2017. The aims of this study are to explore the proportion of prescribing error from pre-printed prescriptions and ...
Nisa Sae-lim, Ploylarp Lertvipapath
doaj   +1 more source

Adverse drug reaction reporting form

Безопасность и риск фармакотерапии, 2018
.
Editorial Article
doaj   +5 more sources

Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis

Frontiers in Pharmacology, 2021
Background and Purpose: Activation of hepatic stellate cells (HSC) is a central driver of liver fibrosis. 5-lipoxygenase (5-LO) is the key enzyme that catalyzes arachidonic acid into leukotrienes.
Shiyun Pu, Shiyun Pu, Yanping Li, Qinhui Liu, Xu Zhang, Lei Chen, Lei Chen, Rui Li, Rui Li, Jinhang Zhang, Jinhang Zhang, Tong Wu, Tong Wu, Qin Tang, Qin Tang, Xuping Yang, Xuping Yang, Zijing Zhang, Zijing Zhang, Ya Huang, Ya Huang, Jiangying Kuang, Jiangying Kuang, Hong Li, Hong Li, Min Zou, Wei Jiang, Jinhan He, Jinhan He   +28 more
doaj   +1 more source